Verisol® collagen peptides
Proksch et al., Skin Pharmacology and Physiology, 2014
- Design
- randomised, double-blind, placebo-controlled
- Sample
- n = 114 women aged 45–65
- Duration
- 8 weeks
- Outcome
- Reduced eye-wrinkle volume and increased type I procollagen versus placebo.
Trial dose 2.5 g/day; the tablet delivers 1 g.
Read the science →
